Royce & Associates Portfolio holdings
Top Buys
| 1 |
MDCO
Medicines Co
MDCO
|
+$50.1M |
| 2 |
Genesco
GCO
|
+$46.4M |
| 3 |
Dana Inc
DAN
|
+$41.3M |
| 4 |
KW
Kennedy-Wilson Holdings
KW
|
+$31.1M |
| 5 |
JBTM
JBT Marel
JBTM
|
+$30.8M |
Top Sells
| 1 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$87.3M |
| 2 |
ATMI
A T M I INC
ATMI
|
+$83.8M |
| 3 |
Teradyne
TER
|
+$81M |
| 4 |
Westlake Corp
WLK
|
+$54.5M |
| 5 |
Helmerich & Payne
HP
|
+$53.5M |
Sector Composition
| 1 | Industrials | 23.38% |
| 2 | Technology | 16.32% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 9.81% |
| 5 | Materials | 9.68% |
Similar funds
Royce & Associates's Q1 2014 Portfolio in Review
As of Q1 2014, Royce & Associates held 1,528 positions worth $33.9B, down 3% from $34.9B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Royce & Associates withdrew a net $1.27B in Q1 2014, closing 116 positions and reducing 505 holdings. Its most notable exit was ARDEN GROUP INC CL-A, an estimated $34.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in Neenah, Inc. Common Stock worth $23.5M.
- Royce & Associates's largest Q1 2014 buy was Neenah, Inc. Common Stock: 454,500 shares worth $23.5M.
- Royce & Associates added most to Medicines Co in Q1 2014, an estimated $50.1M increase.
- Royce & Associates's biggest Q1 2014 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $87.3M.
- Royce & Associates fully exited ARDEN GROUP INC CL-A in Q1 2014, selling an estimated $34.3M.
- Royce & Associates's ten largest holdings make up 9.8% of its $33.9B portfolio in Q1 2014.
- Royce & Associates opened 93 new positions and closed 116 in Q1 2014.
- Royce & Associates's portfolio value fell 3% quarter-over-quarter to $33.9B.
Based on Royce & Associates's 13F filing for Q1 2014, filed 12 May 2014.